Choose JUST ONE of the following: headache, CVA, acute bacterial meningitis, Alzheimer’s, anxiety, depression, or chronic pain syndrome. Then, talk about the pathophysiologic process at play.
Discuss the effects of the selected syndrome’s or disease’s current evidence-based therapy options on the progression of the disease.
To find the most recent standards of care/treatment modalities, conduct an evidence-based literature search using professional association guidelines and peer-reviewed articles (www.guideline.gov) (Links to an external site.). Although these publications and recommendations may be mentioned, they should not be reproduced verbatim into the clinical case presentation. Cite no less than three sources.
In your clinical case presentation, be sure to include the following:
a review of the disease’s pathogenesis, including symptoms and indicators.
An explanation of diagnostic tests and the justifications behind them.
a study of several evidence-based therapeutic approaches for the condition, either from guidelines.gov or a specialist group.
Answer the following inquiries next:
What implications does this case’s information have for a master’s-prepared nurse’s practice?
How might the nurse who has completed a master’s program use this knowledge to create a patient education session for someone with this condition?
What evidence did this case contain that was most crucial?
What was the information in this case that was the most difficult or perplexing to understand?
Mention a patient safety concern that can be resolved for a patient with the circumstance described in this instance.
Overview
A neurological condition known as a stroke is characterized by blood vessel obstruction. Brain clots prevent blood from flowing properly, obstructing arteries and causing blood vessels to burst, which causes bleeding. The abrupt death of brain cells due to a lack of oxygen occurs when the arteries leading to the brain are ruptured during a stroke. Stroke can also result in dementia and depression.
Prior to the publication of the International Classification of Illness 11 (ICD-11) in 2018, stroke was categorized as a blood vessel disease. The severity and particular illness burden of stroke were grossly misrepresented by the inclusion of clinical data from stroke patients in the cardiovascular diseases chapter under the prior ICD coding rationale.
Stroke patients and researchers did not receive government assistance or grant funding intended for neurological disorders as a result of this incorrect classification within the ICD. The actual nature and significance of stroke were finally acknowledged in the ICD-11, and stroke was reclassified within the neurological chapter as a result of persistent advocacy from a group of clinicians [1]. Since stroke has been reclassified as a neurological disorder, data collection and statistical analysis have improved, promoting advancements in acute healthcare and the acquisition of financing for stroke research.
The second biggest cause of death worldwide is stroke. Each year, it affects 13.7 million people and kills about 5.5 million. Between 1990 and 2016, the prevalence of ischemic infarctions, which account for around 87% of strokes, increased significantly.
The majority of strokes are caused by primary (first-time) hemorrhages, while secondary (second-time) hemorrhages account for between 10 and 25 percent [2,3]. Over the period 1990–2016, the incidence of stroke increased in low- and middle-income countries, while it decreased by 42% in high-income nations. The Global Cost of Disease Study (GBD) reports that although the prevalence of stroke has reduced, the age, sex, and location of those affected have resulted in an increase in the socioeconomic burden of stroke over time.
